Cargando…
In Vivo Phenotypic Screening for Treating Chronic Neuropathic Pain: Modification of C2-Arylethynyl Group of Conformationally Constrained A(3) Adenosine Receptor Agonists
[Image: see text] (N)-Methanocarba adenosine 5′-methyluronamides containing 2-arylethynyl groups were synthesized as A(3) adenosine receptor (AR) agonists and screened in vivo (po) for reduction of neuropathic pain. A small N(6)-methyl group maintained binding affinity, with human > mouse A(3)AR...
Autores principales: | Tosh, Dilip K., Finley, Amanda, Paoletta, Silvia, Moss, Steven M., Gao, Zhan-Guo, Gizewski, Elizabeth T., Auchampach, John A., Salvemini, Daniela, Jacobson, Kenneth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266358/ https://www.ncbi.nlm.nih.gov/pubmed/25422861 http://dx.doi.org/10.1021/jm501021n |
Ejemplares similares
-
Purine (N)-Methanocarba Nucleoside
Derivatives Lacking an Exocyclic Amine as Selective A(3) Adenosine
Receptor Agonists
por: Tosh, Dilip K., et al.
Publicado: (2016) -
Structural Probing of Off-Target G Protein-Coupled Receptor Activities within a Series of Adenosine/Adenine Congeners
por: Paoletta, Silvia, et al.
Publicado: (2014) -
Repurposing of a Nucleoside Scaffold from Adenosine
Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018) -
Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A(3 )adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse hearts
por: Wan, Tina C, et al.
Publicado: (2011) -
Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
por: Jacobson, Kenneth A., et al.
Publicado: (2019)